Abstract:Aim To assess the clinical and radiographic outcome of partial pulpotomy by comparing MTA Angelus and Total Fill BC, as pulpotomy agents, in mature teeth with deep caries and symptoms indicative of irreversible pulpitis. Methodology The study was designed as parallel‐two arm, double blind, randomized superiority clinical trial (RCT) registered at www.clinicaltrials.gov (NCT04870398). Symptomatic mature permanent teeth with deep caries fulfilling the inclusion criteria were randomly treated using either MTA Angelus or Total Fill BC. Partial pulpotomy was performed and following complete haemostasis, the capping material was placed over the remaining pulp tissue and a postoperative periapical radiograph was taken. Clinical and radiographic follow‐up evaluation was performed for a median time of 2 years whereas levels of pain intensity were evaluated preoperatively and for 7 days after intervention using Visual Analogue Scale (VAS). For the primary outcome, (failure/success of treatment), Kaplan‐Meier survival curves for the capping materials were plotted and a log‐rank test for equality of survivor functions was applied. A multivariable random effects Cox Regression model was also applied. For the secondary outcome, (post‐operatively reported pain), a multivariable mixed effects ordinal logistic regression was structured. Results One hundred and thirty‐seven teeth in 123 patients underwent partial pulpotomy using randomly either MTA Angelus (N=74), or Total Fill BC (n=63). The percentage failure for MTA Angelus and Total Fill BC was 10.8% (8/74) and 17.5% (11/63) respectively, but the difference was not statistically significant (adjusted HR: 1.83; 95%CI: 0.68, 4.91; p= 0.23). Weak evidence was found that secondary caries involvement may impose 3.54 times greater hazard for treatment failure (adjusted HR: 3.54; 95%CI: 1.00, 12.51; p= 0.05). For each passing minute of procedural bleeding control, there was also 57% higher hazard for treatment failure (adjusted HR: 1.57; 95%CI: 0.99, 2.48; p=0.05). The odds for higher post‐operative pain were 4.73 times greater for the Total Fill BC compared to MTA Angelus (adjusted OR: 4.73; 95%CI: 2.31, 9.66; p<0.001). Conclusions Both materials exhibited similar and favorable outcome rates after partial pulpotomy in teeth with deep caries and symptoms of irreversible pulpitis. Total Fill BC was associated with higher level of postoperative pain intensities.

Effectiveness of Three Agents in Pulpotomy Treatment of Permanent Molars with Incomplete Root Development: A Randomized Controlled Trial

One-year Radiographic and Clinical Performance of Bioactive Materials in Primary Molar Pulpotomy: A Randomized Controlled Trial

A Randomized Controlled Clinical Trial Comparing Clinical and Radiographic Success Rates of MTA and rhBMP2 in Pulpotomy of Primary Teeth

Randomized clinical trial of pulpotomy using a premixed injectable calcium silicate cement on mature permanent teeth with reversible pulpitis

THREE-YEAR OUTCOME OF DIODE LASER PULPOTOMY OF PRIMARY MOLARS USING THREE PULP CAPPING AGENTS: A SPLIT-MOUTH RANDOMIZED CLINICAL TRIAL

Partial pulpotomy success in primary molars followed up for 24 months: A randomized controlled clinical trial using mineral trioxide aggregate, biodentine, and acemannan

Outcomes of root canal therapy or full pulpotomy using two endodontic biomaterials in mature permanent teeth: a randomized controlled trial

Comparing effectiveness of mineral trioxide aggregate, bioceramic putty and tannic acid in maintaining pulp vitality after experimental pulpotomy in rats

A Prospective Randomised Clinical Trial Evaluating Pulpotomy in Primary Molars With Three Bioceramic Calcium Silicate Cements: 24 Month Follow‐Up

Comparative assessment of titanium-prepared platelet-rich fibrin, EndoSequence root repair material, and calcium hydroxide as pulpotomy agents in permanent teeth with irreversible pulpitis: A randomized controlled trial

Clinical and radiographic comparison of primary molar pulpotomy using formocresol, portland cement, and NeoMTA plus: a randomized controlled clinical trial

Primary molar pulpotomies with different hemorrhage control agents and base materials: A randomized clinical trial

Partial Pulpotomy Of Immature Teeth With Apical Periodontitis Using Bioceramics And Mineral Trioxide Aggregate: A Report Of Three Cases

Comparison of Clinical and Radiographic Success between MTA and Biodentine in Pulpotomy of Primary Mandibular Second Molars with Irreversible Pulpitis: A Randomized Double-Blind Clinical Trial

Treatment outcome of partial pulpotomy using two different calcium silicate materials in mature permanent teeth with symptoms of irreversible pulpitis. A randomized clinical trial.

Direct Pulp Capping of Primary Molars with Calcium Hydroxide or MTA Following Hemorrhage Control with Different Medicaments: Randomized Clinical Trial

Comparison of clinical outcomes between mineral trioxide aggregate and bioceramic materials in pulpotomy for treating early chronic pulpitis in deciduous teeth

Clinical and Radiographic Evaluation of Mineral Trioxide Aggregate and Human Amniotic Membrane Pulpotomy in Primary Molars: A Randomized Clinical Trial

Optimal outcomes of pulpotomy in young patients: Long-term prospects for permanent molars with signs and symptoms indicative of irreversible pulpitis

Comparative Evaluation of Success of NeoPutty Mineral Trioxide Aggregate® with Formocresol as Pulpotomy Medicaments in Primary Molars: A Clinical Study

A Randomized Controlled Clinical Trial of the Performance of Three Bioactive Endodontic Cements in Primary Molar Teeth Diagnosed with Reversible Pulpitis: 1-Year Follow-Up Study